LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Operating Expenses | 3,213 | 671 | 469 | 423 | 904 |
| Operating Income | -3,213 | -671 | -469 | -423 | -904 |
| Other Income | -4,484 | 5,955 | -12,856 | 3,993 | 5,618 |
| Pre-tax Income | -7,697 | 5,284 | -13,325 | 3,570 | 4,714 |
| Net Income Continuous | -7,697 | 5,284 | -13,325 | 3,570 | 4,714 |
| Net Income | $-7,697 | $5,284 | $-13,323 | $3,570 | $4,714 |
| EPS Basic Total Ops | -33.50 | 122.00 | -1,590.00 | 334.50 | 19.50 |
| EPS Basic Continuous Ops | -33.17 | 126.29 | -1,575.13 | 334.90 | 19.02 |
| EPS Diluted Total Ops | -33.50 | 0.00 | -1,250.50 | 14.00 | 0.50 |
| EPS Diluted Continuous Ops | -33.17 | 0.05 | -1,235.49 | 13.86 | 0.42 |
| EBITDA(a) | $-3,213 | $-671 | $-469 | $-423 | $-904 |